# How Amicus Embedded Patient Advocacy into its Corporate DNA

Page: https://stenobird.com/podcast/pharmatalkradio-7131046/how-amicus-embedded-patient-advocacy-into-its-corporate-dna
Text version: https://stenobird.com/podcast/pharmatalkradio-7131046/how-amicus-embedded-patient-advocacy-into-its-corporate-dna.md
Podcast: [PharmaTalkRadio](https://stenobird.com/podcast/pharmatalkradio-7131046)
Published: 2026-01-29T16:18:09+00:00
Episode link: https://www.spreaker.com/episode/how-amicus-embedded-patient-advocacy-into-its-corporate-dna--69667685
Audio file: https://dts.podtrac.com/redirect.mp3/api.spreaker.com/download/episode/69667685/jayne_amicus_keynote.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/pharmatalkradio-7131046/episodes/how-amicus-embedded-patient-advocacy-into-its-corporate-dna
Duration seconds: 1517

## Resource

About this podcast: In this keynote from Patients as Partners in Clinical Research 2025, Amicus Therapeutics' Chief Patient Advocate, Jayne Gershkowitz, shares how their organization established and embedded patient advocacy into their core structure for lasting impact. More specifically, Ms Gershkowitz focuses on: Defining role standards and recruiting the right talent Co-creatin research with patient communities and developing patient-centered outcomes Generating metrics that demonstrate the impact on R&D

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/pharmatalkradio-7131046/episodes/how-amicus-embedded-patient-advocacy-into-its-corporate-dna/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/pharmatalkradio-7131046/how-amicus-embedded-patient-advocacy-into-its-corporate-dna.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.